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Introduction. We analyzed the ability of four balance assessments to predict falls in people with Parkinson Disease (PD)
prospectively over six and 12 months. Materials and Methods. The BESTest, Mini-BESTest, Functional Gait Assessment (FGA),
and Berg Balance Scale (BBS) were administered to 80 participants with idiopathic PD at baseline. Falls were then tracked for
12 months. Ability of each test to predict falls at six and 12 months was assessed using ROC curves and likelihood ratios (LR).
Results. Twenty-seven percent of the sample had fallen at six months, and 32% of the sample had fallen at 12 months. At six
months, areas under the ROC curve (AUC) for the tests ranged from 0.8 (FGA) to 0.89 (BESTest) with LR+ of 3.4 (FGA) to 5.8
(BESTest). At 12 months, AUCs ranged from 0.68 (BESTest, BBS) to 0.77 (Mini-BESTest) with LR+ of 1.8 (BESTest) to 2.4 (BBS,
FGA). Discussion. The various balance tests were eﬀective in predicting falls at six months. All tests were relatively ineﬀective at 12
months. Conclusion. This pilot study suggests that people with PD should be assessed biannually for fall risk.
1. Introduction
Postural instability is a common cause of falls in people
with Parkinson disease (PD) [1]. In contrast to community-
dwelling adults over age 65, approximately one-third of
whom report falling each year [2], up to 70% of individuals
with PD fall once annually, while 50% fall twice or more in
a one year period [3, 4]. Falls lead to a myriad of com-
plications [5] that can aﬀect not only physical health, but
also the psychological health of the individual. Hip fracture
and head trauma are two of the most common physical
problems incurred by an individual with PD following a fall
[6], while the psychological complications include fear of
falling [7, 8] and reduced quality of life [9]. Such fall-related
complications are associated with substantial economic costs
[10, 11] and indicate an urgent need to identify and protect
those individuals at the greatest risk.
Despite the relatively high prevalence of falls in the PD
population, accurate and useful methods for predicting an
impending future fall, especially during the early stages of
the disease, remain elusive. Fall history, a well-known fall
risk factor among older adults [12], has a limited utility as
a solitary predictive indicator. Although a meta-analysis of
prospective studies of falling in PD found that 57% of indi-
viduals who had a history of falls in the past year fell during
a 3-month surveillance period, so did 21% of individuals
with no history of falls [13]. Moreover, fall incidence alone
does not help to identify underlying contributors to postural
instability specific to PD. People with PD, for example, may
demonstrate impairments in areas of movement control such
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as sensory integration, keeping their center of mass within
their base of support, coordination of anticipatory postural
control tasks [8, 14] as well as medication side eﬀects such
as dyskinesias [15]. For this reason, standardized balance
assessment tools have been recommended to help determine
factors contributing to falls so that therapeutic intervention
targets can be identified [16, 17].
The utility of a variety of clinical balance tests has been
studied. Balance assessments including the Tinetti [18], Berg
Balance Scale (BBS) [19], the Timed Up and Go (TUG) [20],
the Functional Gait Assessment (FGA) [21], and recently
developed Balance Evaluation Systems Test (BESTest) [22]
have been shown to have sensitivity and specificity that
exceeds a random guess, but they still demonstrate a clini-
cally relevant proportion of false-positive and false- negative
predictions [5, 23]. As noted in a previous meta-analysis
[13], new prediction methods are needed. Relatively newly
developed balance assessments such as the Functional Gait
Assessment (FGA) [21], BESTest [22], and Mini-BESTest, a
condensed version of the BESTest [24], have yet to be studied
and compared prospectively.
Regardless of the balance assessment utilized, there have
been eﬀorts to improve the predictive performance on these
balance assessments through diagnosis-specific alterations of
cutoﬀ scores or collective interpretation of multiple tests [15,
23, 25, 26].While thesemethodsmay improve accuracy, their
overall success may be limited by participant’s fall recall bias.
To date, we are unaware of any studies that have examined
and compared whether the length of prospective follow-up
aﬀects the accuracy of fall prediction in persons with PD.
In order to address these gaps in our understanding of fall
prediction in persons with PD, the primary objective of this
study was to compare the relative accuracy for fall prediction
of four common balance assessments at the six-month and
12-month prospective time points. Relative to our primary
objective, we hypothesized that these tests would be useful in
predicting falls prospectively at both six and 12 months, with
better accuracy over the shortest of the two time periods. Our
secondary objective was to compare the predictive accuracy
and the validity indices of the four balance assessments.
Relative to our secondary objective, we hypothesized that
tests such as the FGA, BESTest, and Mini-BESTest that in-
corporate dynamic tasks would demonstrate improved pre-
dictive ability compared to the BBS.
2. Methods
2.1. Participants. We recruited participants using contact in-
formation gathered from the Washington University School
of Medicine’s Movement Disorders Center database and the
Volunteers for Health database. Participants were recruited
as part of a larger study [27]. Individuals were included if
they had a medical diagnosis of idiopathic PD (Hoehn and
Yahr (H&Y) Stages I–IV), were over the age of 40 and were
community dwellers. Study candidates were excluded if they
had atypical parkinsonism or previous surgical management
of PD (pallidotomy or deep brain stimulation). Prior to
participation, each participant provided written informed
consent in accordance with the policies and procedures of
Washington University School of Medicine’s Human Re-
search Protection Oﬃce.
2.2. Data Collection. Participants were evaluated at baseline
utilizing four balance tests (BBS, FGA, BESTest, and Mini-
BESTest) as described below under Balance Assessments.
Participants were then followed for 12 months, with fall
incidence determined through participant’s report at the
six-month and 12-month time points. An individual was
considered a faller if he or she reported two or more falls
over the surveillance period of interest (0–6 months or 0–12
months). An individual was considered a nonfaller if he or
she reported zero or one falls during the surveillance period.
2.3. Balance Assessments. The BBS is a well-established bal-
ance measure consisting of 14 items (sit to stand, transfers,
forward reach, etc.) used to determine whether or not one
may be at risk for falls [28]. The BBS does not evaluate the
balance during walking. It has been shown to be reliable
when used to assess balance in people with PD [29]. Each
item is scored on a scale of zero (indicating impaired
balance) to four (indicating no impairment in balance), with
a maximum possible score of 56.
The FGA [21] is a 10-item test of dynamic balance in
which all components are evaluated while the participant is
walking. Items performed by the participant include forward
and backward walking as well as walking while turning
the head, changing walking speeds, stepping over obstacles,
and walking with a narrow base of support. When used to
evaluate individuals with PD, this test had high interrater and
test-retest reliability [23]. Each item is scored on a scale of
zero (indicating loss of balance, increased time to perform
task, significantly altered gait pattern) to three (indicating no
impairment of gait or balance and completion of the task in
a timely manner), with a maximum possible score of 30.
The BESTest [22] is a measure designed to evaluate bal-
ance control via 36 items that are divided into six sections
(biomechanical constraints, stability limits and verticality,
anticipatory postural adjustments, postural responses, sen-
sory orientation, and stability in gait). Items in the BESTest
include selected items from the aforementioned assessments
(i.e., BBS and FGA) as well as items such as center of
mass alignment, hip and ankle strength, sitting verticality
and lateral lean, andmultidirectional compensatory stepping
correction, among others. The BESTest has high interrater
and test-retest reliability in PD [23]. Each item is scored on a
scale of zero (indicating poor balance or inability to complete
task) to three (no impairment in balance), with a maximum
score of 108 points.
A shortened version of the BESTest, the Mini-BESTest,
was designed “to improve the structure and measurement
qualities” of the BESTest [24]. This shorter version can be
administered more quickly than the full BESTest, thereby
reducing clinician and patient burden. The Mini-BESTest is
a 14-item balance evaluation that concentrates on dynamic
balance and its components are derived from four of the
six BESTest sections. Items are scored on a scale of zero
(poor balance) to two (no impairment of balance), with
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amaximum possible score of 32 as two of the 14 items receive
two separate scores for diﬀerent aspects of the tasks [30].
2.4. Procedures. All balance assessments were administered
in the Locomotor Control Laboratory at Washington Uni-
versity School of Medicine by a trained physical therapist.
Baseline assessments of participants began in July and ended
in December of 2009. All participants maintained their
normal medication regimen so that they were tested in the
“on” phase of their medication, one to two hours after
medication intake. Demographic information, fall incidence,
and Movement Disorder Society Unified Parkinson Disease
Rating Scale Motor Subscale III (MDS-UPDRS-III) scores
were obtained prior to administration of balance assessments
[31, 32]. Regarding fall incidence, participants were followed
prospectively and at six months reported how many times
they fell in the period from baseline to six months. At 12
months, participants reported how many times they fell
in the period between six and 12 months, with number
of falls from 0 to 12 months determined by adding the
two reports together. Participants chose from the following
answers: (1) none, (2) one time, (3) 2–10 times, (4) weekly,
or (5) daily. An individual was classified as a faller if he
experienced two or more falls in the period of interest (i.e.,
from baseline to six months or from baseline to 12 months).
The order of balance assessments was as follows: BBS, FGA,
and BESTest. Mini-BESTest scores were derived from the
BESTest item scores, as all items on the Mini-BESTest are
included in the BESTest. Items that were duplicated among
the BBS, FGA, and BESTest were performed only once and
scored appropriately for each tool. For example, a sit-to-
stand transfer task is in the BBS and BESTest; therefore it was
only performed once and scored by the rater according to the
criteria listed on each tool.
2.5. Data Analysis. In order to test our primary hypoth-
esis, receiver operating characteristic curves (ROCs) were
constructed for each balance assessment at each time point
(six and 12 months) and the area under the curve (AUC)
was determined for each test at each time point. Using
previously established cutoﬀ scores [23], we determined the
area under the curve (AUC), positive and negative likelihood
ratios, and posttest probabilities for each test at each time
point [33–35]. The time point that consistently produced
the balance assessments with higher AUC and positive LR as
well as lower negative LR would be interpreted as the more
accurate time point. Once that determination was made, we
examined our secondary objective and hypothesis through
the use of empirical tests for noninferiority that were used to
make pairwise comparisons of the AUC for each test (P <
0.05) [36]. Point estimators and interval estimators (95%
confidence intervals [95% CI]) were calculated for all AUC
and likelihood ratio values.
3. Results
Baseline evaluations were completed on 80 participants.
Of the original cohort, 51 participants (41% male) com-
pleted the six-month evaluation, and 40 participants (40%
Table 1: Demographics.
6-Month Group
(n = 51)
12-Month Group
(n = 40)
Age 67.5± 8.8 67.3± 9.5
Years with diagnosis 7.7± 3.9 7.2± 4.1
UPDRS motor score 39.3± 13.3 37.8± 13.1
H&Y stages 2.4± 0.6 2.3± 0.6
Fallers (pretest
probability of falling)
14/15 (0.275) 13/40 (0.325)
male) completed the 12-month evaluation (Table 1). At
six months, 14 individuals (27%) were considered fallers,
while 13 individuals (32%) were considered fallers at 12
months. Regarding reasons for dropout at six months, 15
participants were unable to be contacted or gave no reason
for discontinuing, nine experienced a decline in condition
or an unrelated medical condition, one had transportation
diﬃculty, one participant experienced family problems, and
three participants had incomplete data sets. At 12 months,
in addition to those who had dropped out by six months,
four participants were unable to be contacted or gave no
reason for discontinuing, three experienced a decline in
condition or an unrelated medical condition, and four
participants had incomplete data sets. Of the 11 individuals
that were lost from six to 12months, seven (threemales) were
characterized as fallers at six months.
3.1. Comparison of Six- and 12-Month Results. At sixmonths,
AUCs for the tests ranged from 0.8 to 0.89, while at 12
months, AUCs ranged from 0.68 to 0.77. At six months
(Table 2(a)), the positive likelihood ratios were greater,
the negative likelihood ratios were lower, and the posttest
probability values were lower (i.e., better) for all for balance
tests than at 12 months (Table 2(b)).
3.2. Individual Test Comparison. Based on the apparent
greater accuracy of the six-month prediction, the individual
tests were compared at the six-month time point to deter-
mine which, if any, was superior to the others in terms of
predictive ability. All tests provided greater accuracy than
a random guess, with AUC point estimators ranging from
0.89 (BESTest) to 0.80 (FGA) and substantially overlapping
95% CIs (Table 2(a), Figure 1). However, noninferiority tests
revealed that the AUC of the BESTest was superior to that of
all other tests. Noninferiority tests also showed that the FGA
was inferior to all other tests (Table 3).
4. Discussion
Previous prospective studies of fall prediction have utilized
varied lengths of follow-up period [5, 13]. However, to
our knowledge, no previous work has directly compared
the accuracy of fall prediction at diﬀerent follow-up inter-
vals. Our data confirmed our primary hypothesis that a
shorter follow-up period (six months) consistently produced
more accurate predictions than a longer follow-up period
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Table 2
(a) Predictive values at 6 months.
Balance
measure
AUC (95% CI) Score Sensitivity Specificity LR + (95% CI) LR− (95% CI)
Posttest
probability
with test ≤
cutoﬀ value
Posttest
probability
with test >
cutoﬀ value
BESTest 0.89 (0.74–0.95) ≤69% 0.93 0.84 5.81 (3.69–9.14) 0.08 (0.04–0.17) 0.69 0.03
Mini-
BESTest
0.87 (0.72–0.94) ≤20/32(63%) 0.86 0.78 3.97 (2.68–5.70) 0.18 (0.11–0.78) 0.60 0.07
BBS 0.87 (0.75–0.95) ≤47/56 0.79 0.86 5.64 (3.43–9.27) 0.24 (0.17–0.36) 0.68 0.09
FGA 0.80 (0.62–0.90) ≤15/30 0.64 0.81 3.37 (2.19–5.18) 0.44 (0.34–0.59) 0.56 0.15
(b) Predictive values at 12 months.
Balance
measure
AUC (95% CI) Score Sensitivity Specificity LR + (95% CI) LR− (95% CI)
Posttest
probability
with test ≤
cutoﬀ value
Posttest
probability
with test >
cutoﬀ value
BESTest 0.68 (0.45–0.83) ≤69% 0.46 0.74 1.77 (1.19–2.62) 0.73 (0.59–0.91) 0.46 0.26
Mini-
BESTest
0.77 (0.55–0.89) ≤20/32(63%) 0.62 0.74 2.37 (1.66–3.34) 0.52 (0.39–0.68) 0.53 0.20
BBS 0.68 (0.45–0.82) ≤47/56 0.46 0.81 2.42 (1.53–3.82) 0.67 (0.54–0.82) 0.54 0.24
FGA 0.70 (0.50–0.83) ≤15/30 0.46 0.81 2.42 (1.53–3.82) 0.67 (0.54–0.82) 0.54 0.24
(12 months). In addition, at the six-month follow-up time
point, all of the balance assessments studied provided clin-
ically useful predictive accuracy. Comparisons of the point
estimators and statistical tests of noninferiority suggested
that the BESTest produced the greatest predictive accuracy.
However, it is unclear whether the diﬀerences between the
BESTest and the other balance measures are suﬃciently large
to merit use of one test over another in a clinical setting.
4.1. When Should Fall-Related Screening Take Place? The
recently published American Academy of Neurology quality
of care measures for Parkinson Disease state that persons
with PD should be assessed for fall-related issues “at least
annually [37].” While these guidelines provide targets for
clinicians, they were developed through a consensus building
process that involved expert panel input, public comment,
and stakeholder input, and therefore lacked research-based
support. Our findings of both six- and 12-month predictive
accuracy having AUC values greater than 0.50 (the level of
a random guess) support this metric. However, if clinicians
wish to most accurately assess the risk of falling of a person
with PD, our data suggest that they should consider that
biannual follow-up of persons with PD regarding falls.
4.2. Is One Test Better Than Another? The validity indices
(AUC, positive and negative likelihood ratios) demonstrated
that all of the tests studied provided clinically meaningful
predictive ability. Substantial overlap of the interval esti-
mators agreed with previous studies that have documented
moderate levels of accuracy for the BBS and the FGA [16, 23].
In this sample, the point estimators of the validity indices
and the tests for noninferiority indicated that the BESTest
provided the highest level of accuracy and, for the first
time, provided prospective documentation of its predictive
validity. The BESTest’s likelihood ratio modifications to the
pretest probability of being a faller provide a specific example
of the clinical relevance of these findings. At six months, the
pretest probability of being a faller was 27%. Based on the
BESTest positive likelihood ratio, an individual who scored
below the cutoﬀs for the BESTest increased their posttest
probability of being a faller to 69%. Based on the BESTest
negative likelihood ratio, an individual with a score above the
cutoﬀ reduced their posttest probability of being a faller to
3%. These modifications to the pretest probability are similar
to those observed in other studies of persons with PD [25].
While our results suggested that the BESTest may be
the most accurate as a free-standing test to predict falls in
the absence of other balance assessments, the administration
time of the BESTest is much longer than the other three
assessments. Although the results of this study support its
use when assessing balance and fall risk in individuals with
PD, it is not clear whether the slightly improved accuracy of
the BESTest as compared to the Mini-BESTest or BBS at six
months is enough to merit utilization of the full BESTest in
clinical settings where time constraints must be considered.
We found it surprising that the BESTest, Mini-BESTest,
and BBS outperformed the FGA when used prospectively
over six months. Based on previous research, we hypothe-
sized that more dynamic balance tests such as the BESTest,
Mini-BESTest, and FGA would be more likely to accurately
predict falls than a less dynamic balance test like the BBS
[23, 38]. However, our findings regarding this hypothesis
were mixed, with the FGA having the lowest predictive
accuracy in this sample. Regardless of the FGA findings, our
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Table 3: P Values for 6 month NonInferiority test of AUC.
BESTest Mini-BESTest BBS FGA
BESTest — 0.02 0.04 <0.001
Mini-BESTest 0.13 — 0.14 0.001
BBS 0.23 0.19 — 0.01
FGA 0.83 0.73 0.65 —
First variable in comparison is listed vertically, second variable is listed
horizontally. Bold values indicate significant diﬀerence where first variable
is superior to second variable.
results generally agreed with recent research advocating for
ecologically valid balance assessments [16].
4.3. Limitations and Directions for Future Research. While
our results suggest that balance assessments may be justified
on a biannual basis, these results should be interpreted
with some caution. First, our sample size for this pilot
study was small and representative of a cohort with only
mild-to-moderate PD severity with a smaller percentage of
fallers than seen in previous balance assessment validity
studies. In addition, a moderate number of participants were
lost to follow-up at the six- and 12-month measurement
points. Future research should examine larger samples of
participants over a broader spectrum of disease severity and
perhaps also consider diﬀerent motor phenotypes within PD.
Second, we utilized previously established cut-oﬀ scores
for all of the four balance assessments. These cut-oﬀ scores
still resulted in false-negative and false-positive predictions.
Since cut-oﬀ scores based on validity indices will likely
change depending on the sample being studied, it is impor-
tant to emphasize that cutoﬀ scores should be utilized with
caution and with the appreciation that any and all cutoﬀ
scores are simply guidelines and not definitive boundaries
that separate fallers from nonfallers.
Third, our method of collecting fall incidence data, when
used over a period of six months or more, can lead to an
underreporting of falls [39]. As such, we suggest that future
studies follow more rigorous procedures for collecting fall
incidence data as outlined by Lamb and colleagues [40].
Future studies may also be designed to assess people with PD
oﬀ anti-Parkinson medication to determine whether falls are
more likely during this state.
5. Conclusion
Prospective identification of fall risk for individuals with
PD is extremely important in order to demonstrate a need
for therapeutic intervention aimed at reducing fall risk.
Our comparison of varied duration of follow-up revealed
that a six-month follow-up resulted in greater accuracy
of fall prediction than a 12-month follow-up. In terms of
accuracy of fall prediction during that six-month follow-up
period, all tests provided moderate-to-strong accuracy for
fall prediction with clinically meaningful alterations in the
probability of being a faller. While the BESTest was slightly
more accurate than the other tests, no test eliminated false-
positive and false-negative predictions.
5.1. Rehabilitation Implications. None of the tests examined
possesses acceptable predictive ability in determining who is
at risk for falls within the next 12 months, suggesting the
need for regular balance evaluations every six months among
people with PD. Such a model of preventative evaluation
and treatment twice per year is in keeping with other
models of healthcare, such as the well-established system of
prophylactic dental care in the United States. Such a model
would likely be appropriate and beneficial to apply in the
rehabilitative care of individuals with PD.
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